Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE 2017-18 Annual Report Analysis
Sat, 31 Mar

TTK HEALTHCARE has announced its results for the year ended March 2018. Let us have a look at the detailed performance review of the company during FY17-18.

TTK HEALTHCARE Income Statement Analysis

  • Operating income during the year rose 9.4% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 10.6% YoY during the fiscal. Operating profit margins witnessed a fall and down at 7.4% in FY18 as against 7.3% in FY17.
  • Depreciation charges increased by 27.9% and finance costs increased by 51.8% YoY, respectively.
  • Other income grew by 32.2% YoY.
  • Net profit for the year declined by 3.1% YoY.
  • Net profit margins during the year declined from 3.6% in FY17 to 3.1% in FY18.

TTK HEALTHCARE Income Statement 2017-18

No. of Mths Year Ending 12 Mar-17* 12 Mar-18* % Change
Net Sales Rs m 5,278 5,775 9.4%
Other income Rs m 57 76 32.2%
Total Revenues Rs m 5,335 5,851 9.7%
Gross profit Rs m 385 425 10.6%
Depreciation Rs m 119 152 27.9%
Interest Rs m 31 47 51.8%
Profit before tax Rs m 292 301 3.3%
Tax Rs m 104 120 14.8%
Profit after tax Rs m 187 182 -3.1%
Gross profit margin % 7.3 7.4
Effective tax rate % 35.8 39.7
Net profit margin % 3.6 3.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF

TTK HEALTHCARE Balance Sheet Analysis

  • The company's current liabilities during FY18 stood at Rs 2 billion as compared to Rs 1 billion in FY17, thereby witnessing an increase of 39.9%.
  • Long-term debt down at Rs 7 million as compared to Rs 9 million during FY17, a fall of 24.2%.
  • Current assets rose 53% and stood at Rs 3 billion, while fixed assets rose 24% and stood at Rs 1 billion in FY18.
  • Overall, the total assets and liabilities for FY18 stood at Rs 4 billion as against Rs 3 billion during FY17, thereby witnessing a growth of 41%.

TTK HEALTHCARE Balance Sheet as on March 2018

No. of Mths Year Ending 12 Mar-17* 12 Mar-18* % Change
Networth Rs m 1,575 2,330 47.9
 
Current Liabilities Rs m 1,197 1,675 39.9
Long-term Debt Rs m 9 7 -24.2
Total Liabilities Rs m 2,849 4,027 41.4
 
Current assets Rs m 1,666 2,556 53.5
Fixed Assets Rs m 1,183 1,471 24.3
Total Assets Rs m 2,849 4,027 41.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



TTK HEALTHCARE Cash Flow Statement Analysis

  • TTK HEALTHCARE's cash flow from operating activities (CFO) during FY18 stood at Rs 253 million, an improvement of 42.0% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY18 stood at Rs -226 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY18 stood at Rs -72 million, an improvement of 69% on a YoY basis.
  • Overall, net cash flows for the company during FY18 stood at Rs -41 million from the Rs 1 million net cash flows seen during FY17.

TTK HEALTHCARE Cash Flow Statement 2017-18

Particulars No. of months 12 12 % Change
Year Ending Mar-17 Mar-18
Cash Flow from Operating Activities Rs m 178 253 42.0%
Cash Flow from Investing Activities Rs m 53 -226 -
Cash Flow from Financing Activities Rs m -229 -72 -
Net Cash Flow Rs m 1 -41 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for TTK HEALTHCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 12.9, an decline from the EPS of Rs 24.1 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 1,052.3, stands at 62.9 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 6.4 times, while the price to sales ratio stands at 2.6 times.
  • The company's price to cash flow (P/CF) ratio stood at 45.3 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-17* 12 Mar-18*
Sales per share (Unadj.) Rs 679.3 408.7
TTM Earnings per share Rs 24.1 12.9
Diluted earnings per share Rs 13.3 12.9
Price to Cash Flow x 36.5 45.3
TTM P/E ratio x 57.9 62.9
Price / Book Value ratio x 4.6 6.5
Market Cap Rs m 7,300 15,138
Dividends per share (Unadj.) Rs 5.0 5.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for TTK HEALTHCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 1.5x during FY18, from 1.4x during FY17. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 7.4x during FY18, from 10.4x during FY17. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 7.8% during FY18, from 11.9% during FY18. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 14.9% during FY18, from 20.4% during FY17. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 5.7% during FY18, from 7.7% during FY17. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-17* 12 Mar-18*
Current ratio x 1.4 1.5
Debtors’ Days Days 237 350
Interest coverage x 10.4 7.4
Debt to equity ratio x 0.0 0.0
Return on assets % 7.7 5.7
Return on equity % 11.9 7.8
Return on capital employed % 20.4 14.9
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how TTK HEALTHCARE has performed over the last 5 years, please visit here.

TTK HEALTHCARE Share Price Performance

Over the last one year, TTK HEALTHCARE share price has moved up from Rs 792.8 to Rs 1,052.3, registering a gain of Rs 259.6 or around 32.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,157.6 (down 1.1%). Over the last one year it has moved down from 15,312.4 to 13,157.6, a loss of 2,155 points (down 14.1%).

Overall, the S&P BSE SENSEX is up 12.1% over the year.

(To know more, check out historical annual results for TTK HEALTHCARE and quarterly results for TTK HEALTHCARE)

Annual Report FAQs

What is the current share price of TTK HEALTHCARE?

TTK HEALTHCARE currently trades at Rs 1,535.5 per share. You can check out the latest share price performance of TTK HEALTHCARE here...

What was the revenue of TTK HEALTHCARE in FY18? How does it compare to earlier years?

The revenues of TTK HEALTHCARE stood at Rs 5,851 m in FY18, which was up 9.7% compared to Rs 5,335 m reported in FY17.

TTK HEALTHCARE's revenue has grown from Rs 3,890 m in FY13 to Rs 5,851 m in FY18.

Over the past 6 years, the revenue of TTK HEALTHCARE has grown at a CAGR of 8.5%.

What was the net profit of TTK HEALTHCARE in FY18? How does it compare to earlier years?

The net profit of TTK HEALTHCARE stood at Rs 182 m in FY18, which was down -3.1% compared to Rs 187 m reported in FY17.

This compares to a net profit of Rs 227 m in FY16 and a net profit of Rs 162 m in FY15.

Over the past 6 years, TTK HEALTHCARE net profit has grown at a CAGR of 5.0%.

What does the cash flow statement of TTK HEALTHCARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of TTK HEALTHCARE reveals:

  • Cash flow from operations increased in FY18 and stood at Rs 253 m as compared to Rs 178 m in FY17.
  • Cash flow from investments decreased in FY18 and stood at Rs -226 m as compared to Rs 53 m in FY17.
  • Cash flow from financial activity increased in FY18 and stood at Rs -72 m as compared to Rs -229 m in FY17.

Here's the cash flow statement of TTK HEALTHCARE for the past 6 years.

(Rs m)FY13FY15FY16FY17FY18
From Operations243394374178253
From Investments-5-491-26753-226
From Financial Activity-2029-108-229-72
Net Cashflow218-68-21-41

What does the Key Ratio analysis of TTK HEALTHCARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of TTK HEALTHCARE reveals:

  • Operating profit margins witnessed a fall and down at 7.4% in FY18 as against 7.3% in FY17.
  • Net profit margins declined from 3.6% in FY17 to 3.1% in FY18.
  • Debt to Equity ratio for FY18 stood at 0.0 as compared to 0.0 in FY17.

Here's the ratio/financial analysis of TTK HEALTHCARE for the past 6 years.

 FY13FY15FY16FY17FY18
Operating Profit Margin (%)5.36.17.87.37.4
Net Profit Margin (%)3.73.34.43.63.1
Debt to Equity Ratio (x)0.00.10.00.00.0

Read: Latest Annual Report Analysis of TTK HEALTHCARE

 

Equitymaster requests your view! Post a comment on "TTK HEALTHCARE 2017-18 Annual Report Analysis". Click here!